Aurora Cannabis Inc. (NYSE:ACB) is set to announce first quarter earning results on Monday 9th November 2020, before market open.
The Company Outlook
Revenue for 1Q21 are expected in a range of $ 43.28 million ~ $ 46.16 million
Click Here For More Historical Outlooks Of Aurora Cannabis Inc.
Stock Performance
On Friday, shares of Aurora Cannabis Inc. has traded high as $ 12.18 and has cracked $ 8.12 on the downward trend, reaching $ 9.79 with volume of 461.65 million shares.
According to the previous trading day, closing price of $ 9.79, representing a 69.00 % increase from the 52 week low of $ 3.71 and a 86.21 % decrease over the 52 week high of $ 45.48.
The company has a market capital of $ 1.57 billion and is part of the Healthcare sector and Drug Manufacturers – Specialty & Generic industry.
Recent Analyst recommendations
- On 23rd September 2020, maintained by Piper Sandler at Neutral rating, with $ 8.00 target price.
Conference Call
Aurora Cannabis Inc. will be hosting a conference call at 8:30 AM eastern time on 9th November 2020, to discuss its 1Q21 financial results with the investment community. A live webcast with presentations will be available on the Internet by visiting the Company website auroramj.com
Aurora Cannabis Inc. produces and distributes medical cannabis products. It is vertically integrated and horizontally diversified across various segments of the cannabis value chain, from facility engineering and design to cannabis breeding, genetics research, production, derivatives, high value-add product development, home cultivation, wholesale, and retail distribution.
